online prescription solutions
online discount medstore
pills online
buy lorazepam without prescription
xanax for sale
buy xanax without prescription
buy ambien without prescription
ambien for sale
buy modafinil without prescription
buy phentermine without prescription
modafinil for sale
phentermine for sale
lorazepam for sale
buy lexotan without prescription
bromazepam for sale
xenical for sale
buy stilnox without prescription
valium for sale
buy prosom without prescription
buy mefenorex without prescription
buy sildenafil citrate without prescription
buy adipex-p without prescription
librium for sale
buy restoril without prescription
buy halazepam without prescription
cephalexin for sale
buy zoloft without prescription
buy renova without prescription
renova for sale
terbinafine for sale
dalmane for sale
buy lormetazepam without prescription
nobrium for sale
buy klonopin without prescription
priligy dapoxetine for sale
buy prednisone without prescription
buy aleram without prescription
buy flomax without prescription
imovane for sale
adipex-p for sale
buy niravam without prescription
seroquel for sale
carisoprodol for sale
buy deltasone without prescription
buy diazepam without prescription
zopiclone for sale
buy imitrex without prescription
testosterone anadoil for sale
buy provigil without prescription
sonata for sale
nimetazepam for sale
buy temazepam without prescription
buy xenical without prescription
buy famvir without prescription
buy seroquel without prescription
rivotril for sale
acyclovir for sale
loprazolam for sale
buy nimetazepam without prescription
buy prozac without prescription
mogadon for sale
viagra for sale
buy valium without prescription
lamisil for sale
camazepam for sale
zithromax for sale
buy clobazam without prescription
buy diflucan without prescription
modalert for sale
diflucan for sale
buy alertec without prescription
buy zyban without prescription
buy serax without prescription
buy medazepam without prescription
buy imovane without prescription
mefenorex for sale
lormetazepam for sale
prednisone for sale
ativan for sale
buy alprazolam without prescription
buy camazepam without prescription
buy nobrium without prescription
mazindol for sale
buy mazindol without prescription
buy mogadon without prescription
buy terbinafine without prescription
diazepam for sale
buy topamax without prescription
cialis for sale
buy tafil-xanor without prescription
buy librium without prescription
buy zithromax without prescription
retin-a for sale
buy lunesta without prescription
serax for sale
restoril for sale
stilnox for sale
lamotrigine for sale

STLR Link Roundup – April 16, 2014

Patent Reform Bill Delayed Again

The Senate Judiciary Committee has delayed consideration of the patent reform bill yet again. The bi-partisan bill, aimed at combatting patent trolls or non-practicing entities, was widely expected to go before the committee this week. However, by Monday evening, hopes had begun to fade as negotiations continued into the night. Senator Patrick Leahy, Chairman of the Judiciary Committee, issued a statement promising a new version of the bill would be circulated immediately following the spring recess. The delay may be welcome news for the Partnership for American Innovation (PAI), a lobby launched just this past week, representing industry giants IBM, Apple, Microsoft, Pfizer, and DuPont, among others. Although patent reform is thought to benefit large companies who are often the targets of patent trolls, PAI cautions against imprudent reforms that could threaten the ability to spur innovation particularly with respect to biotechnology and software patents. With such powerful companies joining the fray, it should surprise no one if, post-recess, the bill runs into further delays.

Supreme Court Considers Software Patents

The Supreme Court heard oral arguments on Monday for Alice Corp v. CLS Bank International, a case with potentially serious ramifications on software patents and the tech sector. The case involves patents for a computerized form of escrow and is seen by some as a ripe opportunity for the Court to significantly curb software patents. At Monday’s arguments, however, the Court signaled that it intended to tread carefully, describing the situation as navigating between Scylla and Charybdis.

 

About the Author

Miling Harrington

Miling Harrington is a Staffer for the Columbia Science and Technology Law Review. She is a 2L at Columbia Law School.
blog comments powered by Disqus